/EINPresswire.com/ -- TORONTO, ON--(Marketwired - September 06, 2017) - In a webinar coming up on Tuesday, September 19, 2017, at 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central), industry experts Michael Kuss, Vice President of Strategic Development, Analgesia, at Premier Research and Scott Millard, Executive Director of Strategic Development, Analgesia, at Premier Research, will discuss best practices for conducting clinical trials in osteoarthritis.

It's the leading cause of disability due to pain and the most common form of arthritis, afflicting an estimated 237 million people worldwide. Osteoarthritis (OA) occurs as the cartilage on the end of bones wears down and most often affects the hands, knees, hips, and spine -- though it can damage any joint in the body.

Treating the chronic pain patients experience is among the most enduring challenges in analgesic drug development. In this webinar, the speakers will examine:

• Osteoarthritis as a flexible model for development of new therapies
• Design of clinical trial protocols to address the special needs of the drug being studied
• Study design features that reduce placebo effects
• Typical efficacy scales in OA studies
• Common data analysis methods

To learn more about this complimentary event visit: Chronic Pain: Conducting Clinical Trials in Osteoarthritis

About Premier Research

Premier Research is a leading contract research organization serving the needs of biotechnology, pharmaceutical, and medical device companies worldwide. The company has a wealth of experience in the execution of global, regional, and local clinical development programs, with a special focus on addressing unmet needs in areas such as analgesia, CNS, rare diseases, medical device and diagnostics, oncology, and pediatric research. Premier Research operates in 84 countries and employs more than 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. With its mission to improve productivity in clinical development, the company aligns itself with the mission of its customers to bring new medical treatments to patients promptly, accurately, and cost-effectively.

To learn more about Premier Research visit: premier-research.com

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/9/5/11G145021/Images/Premier_Research_logo-398906951265.jpg